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ABSTRACT
Neurological deficits caused by H-I (hypoxia-ischaemia) to
the perinatal brain are often severely debilitating and lead
to motor impairment, intellectual disability and seizures.
Perinatal brain injury is distinct from adult brain injury in
that the developing brain is undergoing the normal process
of neuronal elimination by apoptotic cell death and thus
the apoptotic machinery is more easily engaged and
activated in response to injury. Thus cell death in response
to neonatal H-I brain injury is partially due to mitochondrial dysfunction and activation of the apoptosome and
caspase 3. An important regulator of the apoptotic
response following mitochondrial dysfunction is XIAP (Xlinked inhibitor of apoptosis protein). XIAP inhibits
apoptosis at the level of caspase 9 and caspase 3
activation, and lack of XIAP in vitro has been shown to
lead to increased apoptotic cell death. In the present study
we show that mice lacking the gene encoding the XIAP
protein have an exacerbated response to neonatal H-I
injury as measured by tissue loss at 7 days following the
injury. In addition, when the XIAP-deficient mice were
studied at 24 h post-H-I we found that the increase in
injury correlates with an increased apoptotic response in
the XIAP-deficient mice and also with brain imaging
changes in T2-weighted magnetic resonance imaging and

apparent diffusion coefficient that correspond to the
location of apoptotic cell death. These results identify a
critical role of XIAP in regulating neuronal apoptosis in vivo
and demonstrate the enhanced vulnerability of neurons to
injury in the absence of XIAP in the developing brain.
Key words: apoptosis, caspase, magnetic resonance
imaging (MRI), neonatal hypoxia-ischaemia, transgenic
mouse, X-linked inhibitor of apoptosis protein (XIAP).

INTRODUCTION
Cerebral H-I (hypoxia-ischaemia) is a major cause of prenatal
brain injury (Volpe, 2001a), and leads to significant
neurological impairments in many of the survivors (Ferriero,
2004). The manifestation of H-I in the developing brain
includes focal ischaemic infarction (Volpe, 2001b) and
selective neuronal necrosis and apoptosis (Hagberg, 1992).
One of the challenges in the field of neonatal brain injury is
prediction of neurological outcome following an hypoxicischaemic event. Similar injury patterns can lead to different
severities and types of outcome in both humans and in
animal models (Vannucci, 1990). Differences in outcome are
likely to be caused by a variety of genetic and environmental

1

Both of these authors contributed equally to this work.
To whom correspondence should be addressed (email holtzman@neuro.wustl.edu).
Abbreviations: Apaf-1, apoptotic protease-activating factor 1; DEVD, Asp-Glu-Val-Asp; H-I, hypoxia-ischaemia; KO, knockout; MR, magnetic resonance; MRI, MR imaging;
P7 etc., post-natal day 7 etc.; TBS, Tris-buffered saline; XIAP, X-linked inhibitor of apoptosis protein.
E 2009 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://
creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is
properly cited.
2

asnneuro.org / Volume 1 (1) / art:e00004
Downloaded from asn.sagepub.com at WASHINGTON UNIV PARENT on March 16, 2016

ASN NEURO AN090005GOS.3d 9/4/09 15:15:21

43

T West and others

risk factors; it is well established that females are more
resistant to perinatal H-I injury than males (Lauterbach et al.,
2001) and, although controversial, an apolipoprotein E
genotype may also affect clinical outcome (Kuroda et al.,
2007; McMichael et al., 2008). Environmental risk factors
probably include energy and antioxidant reserves.
Apoptosis plays an important homoeostatic role in the
normal development of the vertebrate nervous system. In this
environment of naturally occurring apoptotic signalling,
immature neurons are especially vulnerable to insults such
as H-I. The apoptotic cascade involves the activation of
caspases, a family of proteases that cleave cellular substrates
if activated (Cohen, 1997). Caspase activation can be
triggered by translocation of cytochrome c from the
mitochondria to the cytoplasm (Neame et al., 1998), where
cytochrome c induces the formation of the apoptosome, a
complex of cytochrome c, Apaf-1 (apoptotic proteaseactivating factor 1) and pro-caspase 9 (Zou et al., 1999). In
this complex, pro-caspase 9 becomes activated and active
caspase 9 can go on to activate caspase 3 (Wang et al., 2004),
the main contributor to apoptotic cell death following
neonatal H-I (Han et al., 2002). Owing to the prominent role
of apoptosis in neonatal brain injury it is likely that
alterations in the genes and proteins that make up the
apoptotic cascade could affect the severity of outcome
following perinatal H-I injury.
The activity and ability to activate caspases can be
modulated through the activity and expression of a variety
of regulatory proteins, including a family of genes encoding
IAP (inhibitor of apoptosis) proteins. Among these proteins,
XIAP (X-linked IAP) has been found to be a potent inhibitor of
caspase 3 activation (Holcik et al., 2001). XIAP blocks the
activity of activated caspase 9 in the apoptosome by binding
to the neo-N-terminal sequence (ATPF) (Shiozaki et al., 2003),
preventing activation of caspase 3 and, in addition, XIAP can
directly inhibit activated caspase 3 (Deveraux et al., 1998). In
vitro studies have identified endogenous XIAP as a critical
post-cytochrome c regulator of caspase-dependent neuronal
apoptosis (Potts et al., 2003), and data from studies of mice
overexpressing XIAP have shown that increased levels of this
protein confer protection against H-I-induced caspase
activation in both the adult (Trapp et al., 2003) and neonatal
(Wang et al., 2004) brain.
To better understand the anti-apoptotic role of XIAP in
vivo, we investigated the effect of neonatal H-I in XIAPdeficient mice. The rationale for using this in vivo model is
that neuronal injury following neonatal H-I in rodents has
been found to have an apoptotic component which is linked
to mitochondrial dysfunction (Cheng et al., 1998; Gibson et
al., 2001). We found that at 7 days post-injury the XIAP-KO
(knockout) mice have more tissue loss than their wild-type
littermates and that this is a reflection of an increased
apoptotic response to the H-I insult. Interestingly, the
increased tissue loss was specifically observed in the cortex,
an area of the brain that is not as affected by neonatal H-I
injury in C57Bl6 mice. This suggests that XIAP plays an
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important role in protecting cells against apoptotic cell death.
In addition to the biochemical and histological analysis, we
used MRI [MR (magnetic resonance) imaging] to investigate
the injury in vivo at 24 h after the insult. We found that the
changes observed histologically at both 24 h and 7 days postinjury were strikingly reflected by the MRI at 24 h postinjury. Despite the major advantages of MRI (Allegrini and
Sauer, 1992), there are very few publications utilizing MRI in
neonatal models (Aden et al., 2002; Wendland et al., 2008).
The present study demonstrates the ability of MRI to show
areas that correspond to cell death following neonatal H-I
brain injury in the post-natal day (P) 7 mouse, and the ability
to observe the effects of genetic manipulation on the injured
developing brain.

MATERIAL AND METHODS

Animals
Mice deficient in XIAP were obtained from the laboratory of
Dr Craig Thompson (University of Pennsylvania, Philadelphia,
PA, U.S.A.). They were on a C57Bl6 background. In order to
obtain pups of all possible genotypes, breedings were set up
with male XIAP2/y crossed with female XIAP+/2 mice and
male XIAP+/y crossed with female XIAP+/2 mice. Mice were
housed under a 12 h light/dark cycle and observed daily to
establish the date of birth of the pups. Food and water were
provided ad libitum and all care was given in compliance with
National Institute of Health guidelines on the use of
laboratory animals.

Genotyping
XIAP genotyping was performed using primers against the
neomycin-resistance cassette to detect the presence of the
XIAP-KO allele (forward, 59-TGCTCCTGCCGAGAAAGTATCC
ATCATGGC-39; reverse, 59-CGCCAAGCTCTTCAGCAATATC
ACGGGTAG-39). Presence of the intact XIAP gene was
detected using primers for the first exon of the mouse XIAP
gene (forward, 59-TCATTTAACCCCCAGAGAGTTAGCTAGTGC39; reverse, 59-AGAACTCACACCAGATTCACTTCGAACATT-39).
In addition to XIAP genotyping, we also determined the
gender in the animals by PCR. This was done using primers
against SRY (a Y chromosome-specific gene) (forward, 59TTGTCTAGAGAGCATGGAGGGCCATGTCAA-39; reverse, 59CCACTCCTCTGTGACACTTTAGCCCTCCGA-39).

Neonatal H-I
Neonatal H-I was performed on P7 mouse pups with a body
weight between 2.9 and 4.0 g as described previously (West et
al., 2006). Briefly, P7 pups were anaesthetized using 5%
halothane for induction and 1.5% halothane for maintenance
(balance room air). Under anaesthesia, the left carotid artery
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was permanently ligated with a cauterizer through an
incision in the neck. The pups were returned to the dam
and allowed to recover for 1–2 h before being placed in a
hypoxia chamber through which 8% oxygen (balance
nitrogen) flowed for 37 min. Following hypoxia the pups
were returned to the dam until they were killed.

Histology and tissue loss determination
At 7 days post-H-I, P14 pups were deeply anaesthetized with
pentobarbital (200 mg/kg of body weight) and perfused
transcardially with 3 units/ml heparin in PBS, pH 7.4.
Following rapid removal, brains were immersion-fixed in
4% (w/v) paraformaldehyde at 4 ˚C for 24 h, and maintained
in 30% sucrose until freezing in powdered dry ice followed by
sectioning into 50 mm coronal sections with a freezing sliding
microtome. Every 6th section (with an approximate distance
of 300 mm between slides) from the genu of corpus collosum
through to the caudal end of the hippocampus was mounted
and stained with Cresyl Violet as described previously (West et
al., 2006). Slides were scanned at 1600 dpi using the Silverfast
(Lasersoft) plug-in for PhotoShop (Adobe) and saved as TIF
files for analysis.
Tissue loss was calculated as the percentage volume loss by
comparing volumes of distinct brain regions in the injured
(left hemisphere) and non-injured (right hemisphere) hemisphere using the image analysis software SigmaScan Pro 5
(SPSS) (West et al., 2006). Hippocampal volume quantification was performed using the first five sections starting with
the most rostral aspect of the hippocampus. Of those, only
the first four sections were used to determine the cortical
volumes respectively.

Tissue lysis and DEVD (Asp-Glu-Val-Asp)
cleavage activity
Pups were sacrificed 24 h following H-I and perfused
following the procedure described previously (West et al.,
2006). Following brain removal, the right and left hippocampal and cortical regions were dissected on ice and then
frozen on dry ice. Samples were stored at 280 ˚C until the
time of lysis. The right and left brain samples from all animals
were lysed on the same day in 16lysis buffer (Cell Signaling
Technology) with protease inhibitors (Roche) and centrifuged
at 17000 g for 15 min at 4 ˚C. Protein concentrations in the
lysates were determined using a BCA (bicinchoninic acid) kit
(Pierce) and DEVD cleavage activity was measured following a
procedure described previously (West et al., 2006). DEVD
cleavage activity was normalized to total protein concentration for each of the samples and the values were reported as
pmol of AMC (7-amino-4-methylcoumarin) generated per mg
of protein per min.

Western blotting
Remaining tissue lysates not used in the DEVDase assay were
used for Western blot analysis. To resolve high-molecular-

mass proteins, samples were run on 3–8% Tris-acetate
NuPage gels. To resolve low-molecular-mass proteins, 4–
12% Bis-Tris NuPage gels were used (Invitrogen). Based on
the total protein concentration in the lysate, 10 mg of total
sample protein was run per lane. Proteins were transferred on
to nitocellulose membranes (Bio-Rad) and blocked in TBS-T
[Tris-buffered saline (25 mM Tris and 0.15 M NaCl, pH 7.2)
containing 0.125% Tween 20] containing 5% (w/v) fat-free
milk powder. The membranes were incubated with the
following primary antibodies overnight: anti-XIAP (1:1000,
R&D Systems), anti-Apaf-1 (1:1000, Alexis Biochemicals),
anti-spectrin (1:1000, Chemicon), anti-caspase 9 (1:1000,
Sigma) and anti-tubulin (1:4000, Sigma). This was followed by
incubation with the appropriate peroxidase-labelled secondary antibodies (horse anti-mouse used at 1:5000 and goat
anti-rabbit used at 1:5000). Western blots were developed
using either SuperSignal West Pico (Pierce) or ECL Advance
(Amersham) and were visualized on an ImageStation (Kodak).

MRI
MR experiments were performed on a Varian UNITY-INOVA
11.74-T MRI system with a 26-cm clear bore diameter
horizontal Magnex magnet equipped with 8-cm inner
diameter gradient insert assemblies (maximum gradient
strength5120 G/cm). A custom-designed neonatal mouse
holder was used together with a 1.5-cm inner diameter
birdcage coil (Stark Contrast). A standard spin echo was used
for the acquisition of T2-weighted images with the following
parameters: TR (repetition time) 4 s, TE (echo time) 80 ms and
resolution of 936936250 mm.
For MR experiments, P7 animals underwent H-I and were
allowed to recover for 24 h post-injury. The P8 pups were
then anaesthetized using isoflurane and placed into the
animal holder to minimize movement for the duration of the
imaging. The animal holder included a temperature and
respiration probe. During the imaging the animal was kept
under 0.7–1.5% isoflurane anaesthesia (adjusted based on the
respiration rate) and heated air was used to control the
temperature of the animal.

Immunohistochemistry
At the end of the MRI, animals were sacrificed and the brain
tissue was sectioned following the procedure described above
for tissue loss determination. A subset of 50 mm free-floating
sections (every 6th section) were processed for immunohistochemistry. Endogenous peroxidase activity was blocked
with 0.3% H2O2 for 10 min. Non-specific binding was blocked
for 30 min with 3% (v/v) goat serum in TBS and 0.25% Triton
X-100. Sections were incubated with a rabbit antibody
against active caspase 3 (1:1000, Cell Signaling Technologies)
at 4 ˚C overnight, followed by incubation with a biotinylated
secondary antibody (1:2000, Vector). Visualization was
performed using DAB (diaminobenzidine; Sigma) enhanced
with 4% nickel chloride and 0.05% H2O2.
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Statistics
All values are presented as means¡S.E.M. and comparisons
between two groups were performed using a Student’s t test
for parametric data sets and a Mann–Whitney U test for nonparametric data sets. Statistical significance was set at 0.05.
All analysis was performed using GraphPad Prism (GraphPad
Software).

RESULTS

Increased tissue loss in the cortex following
neonatal H-I in XIAP-KO mice
The volume of tissue loss in the injured hemisphere that
occurs following H-I injury to the P7 brain can be assessed 7
days post-injury at P14. Tissue loss 7 days after injury is a
useful histological measure of long term outcome of neonatal
H-I (Cheng et al., 1998; Almli et al., 2000; Gibson et al., 2001).
The damage following neonatal H-I brain injury following
unilateral carotid ligation followed by exposure to hypoxic
conditions in rats and mice is almostly exclusively restricted
to the hemisphere ipsilateral to the ligation and thus the
contralateral hemisphere can serve as a control, based on
which conclusions about the amount of tissue loss in the
same brain can be made (Cheng et al., 1998; Han et al., 2000;
Gibson et al., 2001; West et al., 2006). We calculated the
extent of tissue loss as the percentage volume loss by
comparing the volume of remaining hippocampus and cortex
in the left hemisphere to the volume of the same structures
in the right hemisphere.
We observed a trend for an increase in tissue loss in the
hippocampus of XIAP-KO animals, but this was not significant
owing to the high variability of the injury in the hippocampus
of the mice (Figure 1A). Interestingly we found that tissue
loss in the cortex of XIAP-KO mice [12.1¡3.03%
(mean¡S.E.M.)] was significantly increased by 4-fold as
compared with their wild-type littermates (3.00¡0.75%;
Figure 1B). Previous studies of neonatal H-I in mice have
shown that the cortex is largely spared from H-I injury in
C57Bl6 mice (Gibson et al., 2001; Han et al., 2001; Hagberg et
al., 2004; West et al., 2006; Zhu et al., 2006). We found no
significant differences in injury between males and females
of the same genotype. Mice heterozygous for the XIAP-KO
allele did not have significantly different tissue loss from the
wild-type animals, but did have significantly less cortical
tissue loss than the XIAP-KO mice (results not shown).
However interpretation of data from heterozygous mice is
complicated by the fact that the XIAP gene is on the X
chromosome which is randomly silenced in females.

Caspase 3 activation is significantly increased in
XIAP-KO mice compared with wild-type mice
To further investigate the mechanisms behind the patterns of
tissue loss observed in XIAP-KO mice, we examined the levels
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Figure 1 Tissue loss following neonatal H-I in XIAP-KO and wild-type mice
Tissue loss was measured histologically in the hippocampus (A) and the
cortex (B) of XIAP-KO and wild-type (WT) littermates at 7 days after the H-I
injury. For the hippocampus (A), there is a trend for increased tissue loss in
the hippocampus of XIAP-KO mice, but this does not reach significance due
to the high variability of the injury (values are mean percentage tissue
loss¡S.E.M.). However in the cortex (B) there is significantly more tissue loss
in the XIAP-KO mice than in the wild-type (WT) littermates (values are mean
percentage tissue loss¡S.E.M.). **P50.009, wild-type compared with KO (as
measured by a Student’s t test followed by a Mann–Whitney U post-test). The
number of animals for these experiments was 89 (XIAP-KO n543, wild-type
n546).

of caspase 3 activation in the hippocampus and cortex at 24 h
post-H-I injury. We found that XIAP-KO mice demonstrate
more than a 2-fold increase in caspase 3 activity (measured
by DEVD cleavage) in both hippocampus and cortex,
compared with their wild-type littermates when examined
at 24 h post-injury (Figures 2A and 2B). Thus XIAP is
important for regulation of the caspase activation in both
hippocampus and cortex following neonatal H-I injury.
However owing to the severe injury seen in the hippocampus
of wild-type mice following this injury at P7, including the
very high levels of caspase 3 activity, as well as non-apoptotic
injury that occurs in the hippocampus of wild-type mice (Han
et al., 2002), increased caspase 3 activation in this brain
region did not correspond with an overall increase in tissue
loss seen 7 days later.
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Interestingly, we also observed a significant difference in
caspase 3 activation when comparing caspase 3 activity in the
hemisphere contralateral to carotid ligation in XIAP-KO
compared with wild-type mice (Figures 2A and 2B). This
suggests that the inhibitory role of XIAP in the caspase 3
activation cascade plays a role in the hemisphere contralateral to carotid ligation which, at a pathological level, is
relatively unaffected. No significant differences in DEVDase
activity were observed in XIAP-KO and wild-type non-injured
controls (results not shown). To confirm that the higher level
of caspase 3 activation observed in the XIAP-KO mice is due
to increased proteolytic cleavage of caspase 3 and not just
due to changes in activity of the cleaved enzyme, we
investigated caspase 3 processing by Western blotting
(Figures 3A and 3B). Western blot analysis reveals that

Figure 2 Increased caspase 3 activation in XIAP-KO mice following
neonatal H-I
Caspase 3 activity was measured as the DEVD cleavage in tissue lysates from
the injured (left, L) and non-injured (right, R) hippocampus (A) and cortex (B)
of XIAP-KO and wild-type (WT) littermates at 24 h following the H-I insult.
There is a significant increase in caspase 3 activity in both the hippocampus
and the cortex of the XIAP-KO mice on both the injured and the non-injured
side of the brain. The number of animals for these experiments was 18 (XIAP
KO n511, wild-type, n57). *P,0.05, **P,0.01, ***P,0.001, for wild-type
compared with KO.

XIAP-KO mice have increased levels of both the 17 and 19
kDa forms of cleaved activated caspase 3, suggesting that
XIAP is normally reducing the amount of caspase 3 cleavage
that occurs in wild-type mice following H-I and thus has an
effect upstream of caspase 3 activation. Despite evidence of
increased cleaved caspase 3 in injured XIAP-KO brain tissue,
we noted no difference in pro-caspase 3 between uninjured
XIAP-KO and wild-type brain tissue (results not shown).

Spectrin and caspase 9 cleavage in XIAP-KO mice
Spectrin acts as an endogenous substrate for caspase 3
activation and is cleaved upon caspase 3 activation post
neonatal H-I (Han et al., 2002). In addition to cleavage by
caspase 3, spectrin is also cleaved by calpain, a calciumactivated protease which is thought to be a marker for
necrotic cell death. Previous studies have found that calpain
cleavage of spectrin is independent of caspase activation
(Han et al., 2002; West et al., 2006). In the present study we
wanted to investigate whether there is a difference in caspase
and calpain cleavage of spectrin in the XIAP-KO mice to see if
the increased caspase activation in the XIAP-KO mice is
independent of calpain cleavage. We found a marked increase
in caspase- and calpain-cleaved spectrin in the hippocampus
of both XIAP-KO and wild-type animals at 24 h post-H-I
(Figure 4A). Interestingly, in the XIAP-KO mice the increased
intensity of the calpain-cleaved spectrin band following
injury was similar to the increase in intensity of the caspasecleaved spectrin band suggesting that, in addition to
increased apoptosis in the XIAP-KO mice there is also an
increase in calpain activation. In addition, there was a strong
correlation between the caspase 3-cleaved spectrin and
calpain-cleaved spectrin in both XIAP-KO and wild-type mice
(Figure 4B). This is possibly due to the fact that when cells are
dysfunctional and dying with prominent apoptosis or
necrosis, they are not able to maintain normal ion
homoeostasis leading to an influx of calcium and activation
of calpain.
We also investigated caspase 9 processing by Western
blotting. In addition to autocleavage in the apoptosome of
pro-caspase 9 at Asp315 (generating the p35 form of caspase
9), leading to the generation of the neo-N-terminal sequence
which XIAP can bind to, caspase 9 can also be cleaved by
active caspase 3 at Asp330 (generating the p37 form of
caspase 9). Interestingly, although the caspase 3 cleavage p37
form of caspase 9 was present in both KO and wild-type
animals following H-I injury, the p35 autocleavage-form of
caspase 9 was much higher in the XIAP-KO mice than in wildtype mice (Figure 4A). This increase in the p35 form of
caspase 9 in the absence of XIAP suggests that, in addition to
inhibition of active caspase 9 following autocleavage, XIAP
may be able to directly prevent caspase 9 autocleavage in the
apoptosome in vivo. In non-injured animals, we found no
difference in the levels of cytochrome c, pro-caspase 9, or
Apaf-1 in the hippocampus of wild-type and XIAP-KO mice,
suggesting that lack of XIAP does not otherwise affect the
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Figure 3

Caspase 3 processing in XIAP-KO and wild-type mice
Western blot analysis for caspase 3 was performed on tissue (hippocampus, A and cortex, B) from the injured hemisphere of XIAP-KO
and wild-type (WT) littermates. Pro-caspase 3 is cleaved to form two active forms of caspase 3, the p19 and the p17 form. The
presence of these forms in tissue from both XIAP-KO and wild-type mice show that the lack of XIAP does not affect the processing of
caspase 3 in either the hippocampus or the cortex. Tissue from the right (non-injured) hippocampus and cortex show that there is a
very faint increase in the cleaved form of caspase 3 in the XIAP-KO mice in response to the injury. Western blot analysis for actin is
shown as a loading control although this protein, like most cellular proteins, is actually a substrate of caspase 3 and thus cleaved
when caspase 3 activity is high.

expression of the components of the apoptosome (results not
shown).

No significant difference in the Apaf-1
expression between the cortex and hippocampus
in wild-type animals
The findings of increased apoptosis and tissue loss in the
cortex of XIAP-KO mice, a region of the brain usually not
markedly affected by neonatal H-I in C57Bl6 mice, suggest
that XIAP may play a role in the protection of this region of
the brain in wild-type animals. It has been suggested that the
ratio of Apaf-1 to XIAP may be what is important in
determining whether a XIAP is going to inhibit apoptosis. We
used XIAP and Apaf-1 Western blots to investigate whether
there is a difference in the ratio between the hippocampus
and the cortex in wild-type mice (Figure 5A). Although there
is a slight trend towards a lower Apaf-1 to XIAP ratio in the
cortex compared with the hippocampus, this was not
significant (Figure 5B). In addition to comparing hippocampal
and cortical Apaf-1 expression with XIAP expression, we also
compared Apaf-1 expression with that of other apoptotic
proteins such as cytochrome c, and caspase 3 and 9 (results
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not shown). We found that there was no difference in
expression of these apoptotic proteins between hippocampus
and cortex. Thus it is likely that other factors such as
expression of other proteins, the vascular system, or other
factors are causing the differential vulnerability of the
hippocampus and cortex.

Hippocampal and cortical injury in XIAP-KO mice
can be observed at 24 h post-injury by MRI
In addition to measuring caspase 3 activation at 24 h postinjury, we performed MRI on a set of two XIAP-KO mice and
two wild-type mice. Immediately following MRI, we sacrificed
the animals and sectioned the brains. We found striking
differences in the T2-weighted images at 24 h after H-I,
especially in the cortex, between the wild-type and XIAP-KO
mice that were assessed (Figure 6A). There were areas of
increased T2 signal intensity in the hippocampus, corpus
callosum, and to a very small extent, the cortex in the wildtype mice ipsilateral to carotid ligation. In XIAP-KO mice, the
same areas were affected as in the wild-type mice. However,
T2 changes in the cortex, as well as in the striatum and
thalamus, were much more extensive. To visualize apoptotic
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Figure 4 Spectrin and caspase 9 processing in XIAP-KO and wild-type
mice
Western blot analysis for spectrin, caspase 9 and XIAP was performed on
hippocampal tissue lysates from the injured hemisphere of XIAP-KO and wildtype (WT) littermates. Spectrin is cleaved by calpain to yield p150 and p145,
and by caspase 3 to yield p120. The intensities of these bands correlate with
the activity of the proteases. XIAP-KO mice have increased processing of
spectrin by both caspase 3 and spectrin, suggesting that the increased injury
in these mice also involves activation of calpain. Processing of caspase 9 is
also different between the XIAP-KO and wild-type littermates. The p37
isoform of caspase 9 is caused by autocleavage in the apoptosome, whereas
the p35 isoform is caused by caspase 3 cleavage. In wild-type mice only the
p37 isoform is present, whereas in the XIAP-KO mice both the isoforms are
present. Western blot analysis for XIAP was performed to confirm the
genotype of these animals.

cells, we stained representative sections of the same brains
that matched the coronal sections of the brain that we
imaged using MRI for active caspase 3. Interestingly, the
anatomical regions of MRI hyperintensity corresponded very
well with the regions of neuronal caspase 3 activation. Not
only did the MRI reflect the increased injury in the cortex of
the XIAP-KO mice, it also reflected the anatomical regions
where caspase 3 activation was present in general (hippocampus, cortex, striatum and thalamus).

DISCUSSION
Previous studies have shown that increasing XIAP expression
can protect against H-I-induced injury in both adult (Trapp et

al., 2003) and neonatal (Wang et al., 2004) mice. In addition,
deletion of the XIAP gene has been shown in vitro to increase
neuronal vulnerability to a variety of stressors (Potts PR et al.,
2003; Potts MB et al., 2005; Vaughn and Deshmukh, 2007).
Based on these studies we hypothesized that mice lacking the
endogenous XIAP protein would have an increased apoptotic
response to neonatal H-I brain injury and that the increase in
apoptosis would lead to increased brain injury. The neonatal
rodent H-I model has been found to have an apoptotic
component involving the intrinsic apoptotic pathway leading
to mitochondrial dysfunction (Cheng et al., 1998). Genetic
studies have implicated both pro- and anti-apoptotic
members of the Bcl-2 family in cell death following neonatal
H-I; overexpression of Bcl-X was found to be protective as
was genetic deletion of Bax (Parsadanian et al., 1998; Gibson
et al., 2001). Thus the cell death observed in the neonatal H-I
model is in part due to activation of the intrinsic apoptotic
pathway making this an excellent model for testing the role
of XIAP in vivo. For these studies we used XIAP-deficient
mice. These mice have been previously reported to have no
overt physical or behavioral abnormalities, as well as no
histologically determined differences among selected tissues,
including brain (Harlin et al., 2001), indicating that the
absence of XIAP in the brain does not interfere with postnatal
development of the CNS.
By investigating the tissue loss at 7 days post-injury we
found that the XIAP-KO mice have significantly more tissue
loss in the cortex compared with wild-type littermates. There
was a trend for increased hippocampal injury, but this was
not statistically significant probably due to the high level of
baseline injury to the hippocampus in this model and the
variability in injury observed between the animals. The cortex
is not normally markedly involved in the injury following
neonatal H-I in C57Bl6 mice and thus the cortical injury in
the XIAP-KO mice suggests that XIAP plays a role in
protecting this region of the brain in wild-type mice (Han
et al., 2001; Hagberg et al., 2004; West et al., 2006; Zhu et al.,
2006; West et al., 2007).
In addition to measuring tissue loss at 7 days post-injury,
we also measured caspase 3 activation in both the
hippocampus and cortex at 24 h post-injury. Caspase 3
activation was significantly higher in both the hippocampus
and cortex of XIAP-KO mice compared with wild-type
littermates. It is likely that the caspase 3 activity seen in
wild-type mice in the hippocampus is leading to an almost
maximal amount of tissue loss by this mechanism and thus
potentiating caspase 3 activity in this brain region probably
cannot lead to a greater amount of tissue loss. The increase in
caspase 3 activity in XIAP-KO mice is consistent with the
proposed role of XIAP as a ‘handbrake’ on apoptosis.
Under normal circumstances, cytochrome c release from
the mitochondria leads to formation of the apoptosome
complex where pro-caspase 9 cleaves itself to form active
caspase 9 (Srinivasula et al., 1998). Active caspase 9 produced
in this way can be bound by XIAP, preventing cleavage of
pro-caspase 3 and apoptosis (Shiozaki et al., 2003). Deletion

E 2009 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commerical use, distribution and
reproduction
any medium, provided
the original work
is properly
Downloaded
frominasn.sagepub.com
at WASHINGTON
UNIV
PARENTcited.
on March 16, 2016

ASN NEURO AN090005GOS.3d 9/4/09 15:16:46

49

T West and others

Figure 5

Apaf-1 and XIAP expression in the cortex and hippocampus of wild-type mice
(A) Tissue lysates from both hemispheres (left, L and right, R) of the hippocampus (H) and cortex (ctx) of three P7 wild-type mice
were probed with antibodies against Apaf-1 and XIAP to measure the ratio between these two proteins in these two regions of the
brain. (B) Bands were quantified as relative intensities, and the ratio of Apaf-1 to XIAP was calculated for both the cortex (Ctx) and
the hippocampus (Hip). There was no statistically significant difference between the ratio in the cortex and the hippocampus.

of XIAP relieves the inhibition of caspase 9 cleavage of
caspase 3 in response to cytochrome c release. In addition, to
inhibit caspase 9 cleavage of caspase 3, XIAP can also inhibit
caspase 3 directly (Deveraux et al., 1998). By investigating
caspase 3 processing, we showed that, in XIAP-KO mice, procaspase 3 is cleaved to form the active forms of caspase 3, to
a much higher degree than in wild-type mice. Thus the
increased caspase 3 activity observed in XIAP-KO mice
correlates with increased processing of caspase 3. The fact
that deletion of XIAP causes increased caspase 3 activation
and processing following neonatal H-I suggests that
cytochrome c release, caspase 9 and XIAP all play important
roles in the cell death taking place following neonatal H-I
brain injury.
We also examined caspase 9 processing in XIAP-KO and
wild-type mice by performing Western blot analysis on tissue
from the injured hippocampus of mice of both genotypes at
24 h post-injury. Caspase 9 autocleavage takes place on
Asp315, generating a p35 and a p12 form of caspase 9, but
caspase 9 can also be cleaved by caspase 3 at Asp330,
generating a p37 and a p10 form of caspase 9 (Zou et al.,
2003). Although caspase 3 cleavage of caspase 9 (in the
absence of caspase 9 activation) may not lead to caspase 9
activation (Denault et al., 2007), cleavage of recombinant
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caspase 9 by caspase 3 in vitro does lead to generation of the
p35 isoform of caspase 9 (Zou et al., 2003). We found that the
processing of caspase 9 in wild-type mice leads to the
production of a major p37 isoform (caspase 3 cleavage) with
minimal to no p35 isoform (autocleavage). Interestingly,
there was a significant amount of the caspase 9 autocleavage
(p35) isoform in the injured hippocampus of XIAP-KO mice,
demonstrating that XIAP affects the proteolytic processing of
caspase 9. It is likely that this increased autocleavage of
caspase 9 is due to feedback of caspase 3 on to the
mitochondria. Previous studies have shown that caspase 3
activation can lead to mitochondrial dysfunction and
increased cytochrome c release (Chen et al., 2000; Lakhani
et al., 2006; Chen et al., 2007). Anecdotally, we did observe
increased cytochrome c release in the XIAP-KO mice which
would agree with this hypothesis (results not shown).
The difference in tissue loss in the cortex between XIAP-KO
and wild-type mice suggests that this brain region is not
intrinsically spared from neonatal H-I injury, but rather that
in wild-type mice the level of injury in the cortex does not
reach the threshold at which cell death is initiated. Thus there
may be a difference in the injury threshold between the
hippocampus and cortex. It has been shown in vitro that the
ratio of Apaf-1 to XIAP can determine whether cells are going
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Figure 6

MRI and caspase 3 activation in the brain at 24 h post-injury in XIAP-KO and wild-type mice
At 24 h after neonatal H-I injury two XIAP-KO mice (second row of images) and two wild-type (WT) mice (top row of images) were
imaged using a high-resolution MRI scanner. Following the MRI the mice were killed and the brains were sectioned and stained for
active caspase 3 (bottom two rows). High-resolution MRI allows visualization of individual regions in the brain of the P7 mice at a 50
micron in-plane resolution. The T2 image underscores the difference in the pattern of injury observed in the wild-type and XIAP mice.
Animals of both genotypes have hyperintensity in the hippocampus, but the cortex of the XIAP-KO mice is much more severely
affected than the cortex of the wild-type mice. Immunostaining for active caspase 3 shows a high degree of co-localization with the
injury observed by MRI, suggesting that the MRI changes represent increased cell death and apoptosis.

to undergo apoptosis or survive (Potts PR et al., 2003; Potts
MB et al., 2005). To investigate whether there is a difference
in the ratio of Apaf-1 to XIAP between hippocampus and
cortex we investigated the levels of these proteins in tissue
lysates from wild-type, non-injured P7 animals. We found no
significant difference in this ratio between the two brain
regions, suggesting that the cause for the difference in
vulnerability is not a difference in the ratio of XIAP to Apaf-1.
This, however, does not rule out other factors which may
influence how effective XIAP is at preventing apoptosis.
To investigate whether the changes in injury severity and
patterning observed in the XIAP-KO mice can be observed by
in vivo imaging, we performed MRI on a subset of XIAP-KO
and wild-type littermates. Using a 12T small animal scanner
we were able to get images with less than 100 micron inplane resolution allowing us to clearly differentiate the
different brain structures of the P8 mouse pup. The T2weighted images clearly show the difference in injury severity

between the XIAP-KO and wild-type mice, as well as the
difference in vulnerability of the cortex. When brain sections
from the imaged animals were stained for active caspase 3,
the regions that showed evidence of increased T2 signal on
the MRI corresponded to regions of marked caspase 3
activation. To the best of our knowledge, this is one of the the
first reports of MRI changes observed after brain injury in a
neonatal genetically manipulated mouse, demonstrating the
usefulness of this tool in characterizing injury localization
and injury severity in animals with genetic mutations.
Importantly, MRI should be useful in future studies to
demonstrate regions of cell death in the neonatal brain that
will allow for non-invasive assessment of injury and the
effects of different treatments.
In summary, our results demonstrate that endogenous
XIAP plays an important role in regulating the extent of
apoptotic brain injury in a mouse model of neonatal H-I brain
injury. The fact that loss of function of XIAP can lead to
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vulnerability of the brain to H-I injury suggests that this
variation in the level of function of this protein could
underlie some of the variability in response to injury observed
in the human neonate. Thus differences in XIAP function or
levels are potential risk factors for increasing the neuronal
susceptibility to brain injury. Furthermore, there is an
important need both in pre-term and term human H-I brain
injury for better therapies to improve short- and long-term
outcome. The relevance of XIAP deficiency might bring new
insight in newborns with marked cortical injury in disproportion to the duration of the H-I. It will be important in
future studies to determine whether manipulation of XIAP,
either genetically or pharmacologically, may be of use in
developing better therapeutics to prevent the consequences
of neonatal H-I.
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